Adjuvant chemotherapy after preoperative chemoradiotherapy for rectal cancer

dc.contributor.authorKanyilmaz, G.
dc.contributor.authorKoc, M.
dc.contributor.authorAktan, M.
dc.date.accessioned2024-02-23T14:20:59Z
dc.date.available2024-02-23T14:20:59Z
dc.date.issued2015
dc.departmentNEÜen_US
dc.description.abstractAdjuvant chemotherapy has been very questionable recently. In this regards, the study which was designed by A.J. Breugom and colleagues :'Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Clorectal Cancer Group (DCCG) randomized phase III trial' caught our attention. We read this trial with very interest. However from our point our view there are some limitations of this study and we want to make some suggestion and some criticism for study.en_US
dc.identifier.doi10.1093/annonc/mdv366
dc.identifier.endpage2352en_US
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.issue11en_US
dc.identifier.pmid26347112en_US
dc.identifier.scopus2-s2.0-84947704818en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage2352en_US
dc.identifier.urihttps://doi.org/10.1093/annonc/mdv366
dc.identifier.urihttps://hdl.handle.net/20.500.12452/13395
dc.identifier.volume26en_US
dc.identifier.wosWOS:000365159200022en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherOxford Univ Pressen_US
dc.relation.ispartofAnnals Of Oncologyen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[Keyword Not Available]en_US
dc.titleAdjuvant chemotherapy after preoperative chemoradiotherapy for rectal canceren_US
dc.typeLetteren_US

Dosyalar